Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
Crossref DOI link: https://doi.org/10.1186/s12931-017-0506-0
Published Online: 2017-01-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blasi, F. http://orcid.org/0000-0002-2285-9970
Canonica, G. W.
Miravitlles, M.
Funding for this research was provided by:
laboratori Guidotti (unrestricted grant)
Momento Medico srl